Shenzhen Salubris Pharmaceuticals Co.,Ltd.’s Net Profit Rose 49.9% in First Half of 2022

Shenzhen Salubris Pharmaceuticals Co.,Ltd. (深圳信立泰药业股份有限公司) (002294.SZ) reported a net profit of 347.3 million yuan in the first half of 2022, up 49.9% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, up 21.2% year-on-year.

At the end of the reporting period, it had 9.5 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 19.3%.